VEXAS syndrome: Focus on dermatological manifestations and their histopathological correlate
Abstract Background VEXAS 'Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome' is a rare autoinflammatory syndrome, first described in October 2020 by Beck et al. It is caused by somatic mutations in the UBA1 gene, coding for the E1 enzyme, responsible for ubiquitination. It...
Saved in:
Main Authors: | Sofie Engelen (Author), Anne‐Catherine Dens (Author), Frederik Staels (Author), Rik Schrijvers (Author), Daniel Blockmans (Author), Steven Vanderschueren (Author), Albrecht Betrains (Author), F. J. Sherida H. Woei‐A‐Jin (Author), Arno Vanstapel (Author), Franscesca Bosisio (Author), Petra De Haes (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
VEXAS syndrome with cutaneous nodules
by: Yahya Argobi
Published: (2021) -
A new disorder to keep in mind: VEXAS syndrome
by: Egídio Freitas, et al.
Published: (2024) -
Vulvar Langerhans cell histiocytosis: Clinicopathologic characteristics, mutational profile, and treatment of 4 patients in a single-center cohort
by: Ruben Renier, MD, et al.
Published: (2023) -
Navigating therapeutic challenges in VEXAS syndrome: exploring IL-6 and JAK inhibitors at the forefront
by: Xiao Xiao Li, et al.
Published: (2024) -
VEXAS syndrome presenting as refractory cutaneous Kikuchi disease-like inflammatory pattern responding to tofacitinib
by: Lauren M. Fahmy, BS, et al.
Published: (2023)